cholest-5-ene-3,4-diol has been researched along with Arthritis, Rheumatoid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawakami, J; Naito, T; Ogawa, N; Ohshiro, J; Sato, H; Suzuki, M; Torikai, E | 1 |
| Gjestad, C; Lie, E; Mehus, LL; Molden, E; Olsen, IC; Syversen, SW; Wollmann, BM | 1 |
2 other study(ies) available for cholest-5-ene-3,4-diol and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Relationships between concomitant biologic DMARDs and prednisolone administration and blood tacrolimus exposure or serum CYP3A4/5-related markers in rheumatoid arthritis patients.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biomarkers; Cytochrome P-450 CYP3A; Female; Humans; Hydroxycholesterols; Immunosuppressive Agents; Limit of Detection; Male; Middle Aged; Prednisolone; Tacrolimus; Vitamin D | 2019 |
4β-Hydroxycholesterol Level in Patients With Rheumatoid Arthritis Before vs. After Initiation of bDMARDs and Correlation With Inflammatory State.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; Female; Humans; Hydroxycholesterols; Inflammation; Male; Middle Aged; Young Adult | 2017 |